{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"acute-promyelocytic-leukemia","columns":[{"gene":"","key":"population-10061ef26ac0b42d015e","label":"Acute promyelocytic leukemia","mondoId":"MONDO:0012883","onsetQualifier":null,"originColumnKey":"MONDO:0012883/OMIM:612376","originalViews":[{"key":"MONDO:0012883/OMIM:612376","label":"Acute promyelocytic leukemia","scopeLabel":"OMIM:612376","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["3ce8a2b2da46ff38634f6c698d2bce0586cb298844c000004b9e374eef448899","b5798b2e36bc25371bba4f84ec9b82962dbd8bb41121cb73c7d3da1c6180abe8"],"recordQualifiers":{},"scopeLabel":"OMIM:612376","sourceIds":["OMIM:612376"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-3fc2a9632cc648ea4354","label":"Acute promyelocytic leukemia","mondoId":"MONDO:0012883","onsetQualifier":null,"originColumnKey":"MONDO:0012883/ORPHA:520","originalViews":[{"key":"MONDO:0012883/ORPHA:520","label":"Acute promyelocytic leukemia","scopeLabel":"ORPHA:520","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["08d4fb049c6ab3265ab9fe841ea05f0917e820f60463feb5b82cbcc8229d161d","121d377f3f8eb23642869f4fdec96d7e1e5df2f1fe64b5379d31f6b8334e32d2","14b176ac905df8fc8e45a9f92fd4924875dfcbf3418498845527c33312c34c44","19e2abb185ef89596589029856bb6734a7cf7732b4b286d6e8c1e4b8eb3686e5","2cdd0bee8210fa71eabacdd67ddacb9e53406e12ba7809fefdbb566d1349b57f","35ea6a9acfa90b2ccc82bdc2a8bbe28ff9694f9458a25da6d1262be6649ecf79","375f2109f058ede5339a4176112f0c2805666e46a2061ddd652e7b4ab9189ec6","3d48774bfc942ddb1d3d83b578e4a27bf727d129541c691c28e117d8dd34b86c","4582150e0b0d424c96e1d8446fc01400739661599bb7bda9b8918d77d7fc6c32","4cb223a97d4e88b05a6d3b4f6456e37903f7c6e5437f0e1051ff8d507d18c2e5","50c55780117952a0de7c4cc8cc334ba1435d2f3acb2526ce317821b372ee287a","5f08e1037a0b1877b5a0d16f98ce16d2d445682b180af2aeef1329cc6d6facfe","6134dff885eb992e11ba88a452b6d8a290d9be423cec8f6721c115f90949cfda","6616d3dae55c056f4aa23817c25c62d5b5239680cc7d46ee4a5ca6dcd32d43eb","6669f95c7a5eb3a5eaa34178df6c93a93d7e2c058bdbce09660f5046659c9d06","6952ef34334549afbd0027074eb953c92c97ae376d9fced8c76a8bba9c5cc52d","6d52b0b4e1ae72749a31850cc28f44d04288fecb0f4671e4aaf6ff8035a2ed9e","6f8422671d7b0ed473428ed92d8b1189d74d730caefb4e7ddbc4b9d9e2655a0d","72e03ac9c9a012e4336d2a2f38b13e0b7d7d512da03bf6af52b7d25276696bf8","7b46ed38376ea195ab7c2dd1985ce4dc23c37a33725644de4ec7fbb9cefaa126","8317f47ff695f3945c897b10eaff653370c6348aa034404f21210c45fc7e10c4","8452cbfa647761c2c59c088c565b55fc32c6ed10ea8f05024c27eda242a780b2","ad9532a612e8ae8f1faadaa543721381e9683ae1a910adca2559bd4bf67b4945","b3b1ec80e2d916959e9ce770bf9e1c3eced2b8582fabd6c5c9fa85b159377aa6","b68f6d82d07d245f685cab80b8bacd6a48c8ab8a70f5c002bd4d73502388541c","bed6a36f4f64e1c3da278518654233d6c1372aff6c233d5cf3991657d587720f","c6027048809e00dadd6395a8477a34e24d3b9ee670c13bf18c31415cb8be066d","c8d36e6961b01c4f48dc06cab2f9b1ea1aff14f56e6d0498a733f9bcecfad5e9","ccabe310ab94cdb893bea3337718fad54f1f103fd2569b3bc15f420f8eacc890","d2fbd0d1d6ee520b982dc411432d32882c995993dc8c9194dc84f3cd2433716c","d321944606d57d33ef2eb14fa4626ed6152077b3003c71efdbdfb7c2fda579c6","d49519618e063933c77e8243cec9cb14ac8e3520042643086b7567153b3208da","d5342181b702784cdbaab66f73ead3b13c60c574829dbbe95273fef08f846f8f","e0e7f377959e797073eab7c1c10a4f7cdbea4a5c64289413a0d8441e526223b4","e365d0743761d288bd383deb759f1e9f74d2d34adba6dd4cd0e4051e02980ef3","f75d0fbd97b12926843751c73cf0eade830999b7fab17de3d51c1dc86d5f82a0"],"recordQualifiers":{},"scopeLabel":"ORPHA:520","sourceIds":["ORPHA:520"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-10061ef26ac0b42d015e","population-3fc2a9632cc648ea4354"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002027","HP:0001892","HP:0012135","HP:0004836","HP:0030955","HP:0001903","HP:0002039"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":38,"sourceGroups":{"omim":2,"orphanet":36}},"features":[{"hpoId":"HP:0002027","label":"Abdominal pain","primary":true},{"hpoId":"HP:0001892","label":"Abnormal bleeding","primary":true},{"hpoId":"HP:0012135","label":"Abnormal granulocytopoietic cell morphology","primary":true},{"hpoId":"HP:0004836","label":"Acute promyelocytic leukemia","primary":true},{"hpoId":"HP:0030955","label":"Addictive alcohol use","primary":true},{"hpoId":"HP:0001903","label":"Anemia","primary":true},{"hpoId":"HP:0002039","label":"Anorexia","primary":true},{"hpoId":"HP:0031020","label":"Bone marrow hypercellularity","primary":false},{"hpoId":"HP:0002653","label":"Bone pain","primary":false},{"hpoId":"HP:0000978","label":"Bruising susceptibility","primary":false},{"hpoId":"HP:0031035","label":"Chronic infection","primary":false},{"hpoId":"HP:0001882","label":"Decreased total leukocyte count","primary":false},{"hpoId":"HP:0001875","label":"Decreased total neutrophil count","primary":false},{"hpoId":"HP:0025420","label":"Diffuse alveolar hemorrhage","primary":false},{"hpoId":"HP:0005521","label":"Disseminated intravascular coagulation","primary":false},{"hpoId":"HP:0031364","label":"Ecchymosis","primary":false},{"hpoId":"HP:0000421","label":"Epistaxis","primary":false},{"hpoId":"HP:0002875","label":"Exertional dyspnea","primary":false},{"hpoId":"HP:0012378","label":"Fatigue","primary":false},{"hpoId":"HP:0001945","label":"Fever","primary":false},{"hpoId":"HP:0100758","label":"Gangrene","primary":false},{"hpoId":"HP:0000225","label":"Gingival bleeding","primary":false},{"hpoId":"HP:0000212","label":"Gingival overgrowth","primary":false},{"hpoId":"HP:0000790","label":"Hematuria","primary":false},{"hpoId":"HP:0011900","label":"Hypofibrinogenemia","primary":false},{"hpoId":"HP:0001974","label":"Increased total leukocyte count","primary":false},{"hpoId":"HP:0002716","label":"Lymphadenopathy","primary":false},{"hpoId":"HP:0100608","label":"Metrorrhagia","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0030140","label":"Oral cavity bleeding","primary":false},{"hpoId":"HP:0001876","label":"Pancytopenia","primary":false},{"hpoId":"HP:0000967","label":"Petechiae","primary":false},{"hpoId":"HP:0031245","label":"Productive cough","primary":false},{"hpoId":"HP:0000979","label":"Purpura","primary":false},{"hpoId":"HP:0010280","label":"Stomatitis","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false},{"hpoId":"HP:0002321","label":"Vertigo","primary":false},{"hpoId":"HP:0001824","label":"Weight loss","primary":false}],"ledeHtml":"Acute promyelocytic leukemia is a form of acute myeloid leukemia, a cancer of the blood-forming tissue (bone marrow). In normal bone marrow, hematopoietic stem cells produce red blood cells (erythrocytes) that carry oxygen, white blood cells (leukocytes) that protect the body from infection, and platelets (thrombocytes) that are involved in blood clotting. In acute promyelocytic leukemia, immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a shortage of normal white and red blood cells and platelets in the body, which causes many of the signs and symptoms of the condition.","mondoId":"MONDO:0012883","node":{"canonicalSlug":"acute-promyelocytic-leukemia","comparisons":[{"documentSha256":"733dc7fac60450cd00ce4dfa5f74fadc3fb768dcb72920a4b8e173c872bba942","key":"legacy-cytogenetically-normal-acute-myeloid-leukemia","kind":"legacy","label":"acute myeloid leukemia","memberIds":["MONDO:0007896","MONDO:0012883","MONDO:0017858","MONDO:0018871","MONDO:0018874","MONDO:0019455"],"mondoId":"MONDO:0018874","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cytogenetically-normal-acute-myeloid-leukemia.733dc7fac60450cd00ce4dfa5f74fadc3fb768dcb72920a4b8e173c872bba942.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":["The mutation that causes acute promyelocytic leukemia involves two genes, the PML gene on chromosome 15 and the RARA gene on chromosome 17. A rearrangement of genetic material (translocation) between chromosomes 15 and 17, written as t(15;17), fuses part of the PML gene with part of the RARA gene. The protein produced from this fused gene is known as PML-RARα. This mutation is acquired during a person's lifetime and is present only in certain cells. This type of genetic change, called a somatic mutation, is not inherited.","The PML-RARα protein functions differently than the protein products of the normal PML and RARA genes. The protein produced from the RARA gene, RARα, is involved in the regulation of gene transcription, which is the first step in protein production. Specifically, this protein helps control the transcription of certain genes important in the maturation (differentiation) of white blood cells beyond the promyelocyte stage. The protein produced from the PML gene acts as a tumor suppressor, which means it prevents cells from growing and dividing too rapidly or in an uncontrolled way. The PML-RARα protein interferes with the normal function of both the PML and the RARα proteins. As a result, blood cells are stuck at the promyelocyte stage, and they proliferate abnormally. Excess promyelocytes accumulate in the bone marrow and normal white blood cells cannot form, leading to acute promyelocytic leukemia.","The PML-RARA gene fusion accounts for up to 98 percent of cases of acute promyelocytic leukemia. Translocations involving the RARA gene and other genes have been identified in a few cases of acute promyelocytic leukemia."],"causesUrl":"https://medlineplus.gov/genetics/condition/acute-promyelocytic-leukemia/#causes","contentForm":"summary","matchMethod":"automatic-preferred-name","name":"Acute promyelocytic leukemia","paragraphs":["Acute promyelocytic leukemia is a form of acute myeloid leukemia, a cancer of the blood-forming tissue (bone marrow). In normal bone marrow, hematopoietic stem cells produce red blood cells (erythrocytes) that carry oxygen, white blood cells (leukocytes) that protect the body from infection, and platelets (thrombocytes) that are involved in blood clotting. In acute promyelocytic leukemia, immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a shortage of normal white and red blood cells and platelets in the body, which causes many of the signs and symptoms of the condition.","People with acute promyelocytic leukemia are especially susceptible to developing bruises, small red dots under the skin (petechiae), nosebleeds, bleeding from the gums, blood in the urine (hematuria), or excessive menstrual bleeding. The abnormal bleeding and bruising occur in part because of the low number of platelets in the blood (thrombocytopenia) and also because the cancerous cells release substances that cause excessive bleeding.","The low number of red blood cells (anemia) can cause people with acute promyelocytic leukemia to have pale skin (pallor) or excessive tiredness (fatigue). In addition, affected individuals may heal slowly from injuries or have frequent infections due to the loss of normal white blood cells that fight infection. Furthermore, the leukemic cells can spread to the bones and joints, which may cause pain in those areas. Other general signs and symptoms may occur as well, such as fever, loss of appetite, and weight loss.","Acute promyelocytic leukemia is most often diagnosed around age 40, although it can be diagnosed at any age."],"reviewed":"2011-04","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/acute-promyelocytic-leukemia"},"ownColumnKeys":["population-10061ef26ac0b42d015e","population-3fc2a9632cc648ea4354"],"publication":"published","relationships":[{"kind":"parent","label":"inherited acute myeloid leukemia","mondoId":"MONDO:0017893","slug":"inherited-acute-myeloid-leukemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/538","pageMondoId":"MONDO:0012883","source":"GARD","name":"Acute promyelocytic leukemia","url":"https://rarediseases.info.nih.gov/diseases/538","relationToPage":"same-condition","coveredMondoIds":["MONDO:0012883"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-25T03:38:18Z","upstream":"GARD:0000538","rawAttribution":"MONDO:0012883","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"range","key":"08d4fb049c6ab3265ab9fe841ea05f0917e820f60463feb5b82cbcc8229d161d","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011900","is_excluded":false,"label":"Hypofibrinogenemia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"121d377f3f8eb23642869f4fdec96d7e1e5df2f1fe64b5379d31f6b8334e32d2","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031245","is_excluded":false,"label":"Productive cough","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"14b176ac905df8fc8e45a9f92fd4924875dfcbf3418498845527c33312c34c44","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001882","is_excluded":false,"label":"Decreased total leukocyte count","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"19e2abb185ef89596589029856bb6734a7cf7732b4b286d6e8c1e4b8eb3686e5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030955","is_excluded":false,"label":"Addictive alcohol use","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2cdd0bee8210fa71eabacdd67ddacb9e53406e12ba7809fefdbb566d1349b57f","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001824","is_excluded":false,"label":"Weight loss","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"35ea6a9acfa90b2ccc82bdc2a8bbe28ff9694f9458a25da6d1262be6649ecf79","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002321","is_excluded":false,"label":"Vertigo","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"375f2109f058ede5339a4176112f0c2805666e46a2061ddd652e7b4ab9189ec6","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002875","is_excluded":false,"label":"Exertional dyspnea","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3ce8a2b2da46ff38634f6c698d2bce0586cb298844c000004b9e374eef448899","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:612376","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012135","is_excluded":false,"label":"Abnormal granulocytopoietic cell morphology","onset_id":null,"reference":"OMIM:612376","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"3d48774bfc942ddb1d3d83b578e4a27bf727d129541c691c28e117d8dd34b86c","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4582150e0b0d424c96e1d8446fc01400739661599bb7bda9b8918d77d7fc6c32","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000967","is_excluded":false,"label":"Petechiae","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4cb223a97d4e88b05a6d3b4f6456e37903f7c6e5437f0e1051ff8d507d18c2e5","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001974","is_excluded":false,"label":"Increased total leukocyte count","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"50c55780117952a0de7c4cc8cc334ba1435d2f3acb2526ce317821b372ee287a","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031364","is_excluded":false,"label":"Ecchymosis","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5f08e1037a0b1877b5a0d16f98ce16d2d445682b180af2aeef1329cc6d6facfe","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000212","is_excluded":false,"label":"Gingival overgrowth","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6134dff885eb992e11ba88a452b6d8a290d9be423cec8f6721c115f90949cfda","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6616d3dae55c056f4aa23817c25c62d5b5239680cc7d46ee4a5ca6dcd32d43eb","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000978","is_excluded":false,"label":"Bruising susceptibility","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6669f95c7a5eb3a5eaa34178df6c93a93d7e2c058bdbce09660f5046659c9d06","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001876","is_excluded":false,"label":"Pancytopenia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6952ef34334549afbd0027074eb953c92c97ae376d9fced8c76a8bba9c5cc52d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001945","is_excluded":false,"label":"Fever","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6d52b0b4e1ae72749a31850cc28f44d04288fecb0f4671e4aaf6ff8035a2ed9e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f8422671d7b0ed473428ed92d8b1189d74d730caefb4e7ddbc4b9d9e2655a0d","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002027","is_excluded":false,"label":"Abdominal pain","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"72e03ac9c9a012e4336d2a2f38b13e0b7d7d512da03bf6af52b7d25276696bf8","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000225","is_excluded":false,"label":"Gingival bleeding","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7b46ed38376ea195ab7c2dd1985ce4dc23c37a33725644de4ec7fbb9cefaa126","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031035","is_excluded":false,"label":"Chronic infection","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8317f47ff695f3945c897b10eaff653370c6348aa034404f21210c45fc7e10c4","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005521","is_excluded":false,"label":"Disseminated intravascular coagulation","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8452cbfa647761c2c59c088c565b55fc32c6ed10ea8f05024c27eda242a780b2","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002039","is_excluded":false,"label":"Anorexia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ad9532a612e8ae8f1faadaa543721381e9683ae1a910adca2559bd4bf67b4945","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b3b1ec80e2d916959e9ce770bf9e1c3eced2b8582fabd6c5c9fa85b159377aa6","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031020","is_excluded":false,"label":"Bone marrow hypercellularity","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b5798b2e36bc25371bba4f84ec9b82962dbd8bb41121cb73c7d3da1c6180abe8","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:612376","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0004836","is_excluded":false,"label":"Acute promyelocytic leukemia","onset_id":null,"reference":"OMIM:612376","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b68f6d82d07d245f685cab80b8bacd6a48c8ab8a70f5c002bd4d73502388541c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001875","is_excluded":false,"label":"Decreased total neutrophil count","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bed6a36f4f64e1c3da278518654233d6c1372aff6c233d5cf3991657d587720f","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025420","is_excluded":false,"label":"Diffuse alveolar hemorrhage","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c6027048809e00dadd6395a8477a34e24d3b9ee670c13bf18c31415cb8be066d","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030140","is_excluded":false,"label":"Oral cavity bleeding","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c8d36e6961b01c4f48dc06cab2f9b1ea1aff14f56e6d0498a733f9bcecfad5e9","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100608","is_excluded":false,"label":"Metrorrhagia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ccabe310ab94cdb893bea3337718fad54f1f103fd2569b3bc15f420f8eacc890","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002653","is_excluded":false,"label":"Bone pain","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d2fbd0d1d6ee520b982dc411432d32882c995993dc8c9194dc84f3cd2433716c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d321944606d57d33ef2eb14fa4626ed6152077b3003c71efdbdfb7c2fda579c6","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d49519618e063933c77e8243cec9cb14ac8e3520042643086b7567153b3208da","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010280","is_excluded":false,"label":"Stomatitis","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d5342181b702784cdbaab66f73ead3b13c60c574829dbbe95273fef08f846f8f","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002716","is_excluded":false,"label":"Lymphadenopathy","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e0e7f377959e797073eab7c1c10a4f7cdbea4a5c64289413a0d8441e526223b4","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100758","is_excluded":false,"label":"Gangrene","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e365d0743761d288bd383deb759f1e9f74d2d34adba6dd4cd0e4051e02980ef3","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000979","is_excluded":false,"label":"Purpura","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f75d0fbd97b12926843751c73cf0eade830999b7fab17de3d51c1dc86d5f82a0","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001892","is_excluded":false,"label":"Abnormal bleeding","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/acute-promyelocytic-leukemia\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/538\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012883\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-name</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Acute promyelocytic leukemia is a form of acute myeloid leukemia, a cancer of the blood-forming tissue (bone marrow). In normal bone marrow, hematopoietic stem cells produce red blood cells (erythrocytes) that carry oxygen, white blood cells (leukocytes) that protect the body from infection, and platelets (thrombocytes) that are involved in blood clotting. In acute promyelocytic leukemia, immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a shortage of normal white and red blood cells and platelets in the body, which causes many of the signs and symptoms of the condition.</p><p>People with acute promyelocytic leukemia are especially susceptible to developing bruises, small red dots under the skin (petechiae), nosebleeds, bleeding from the gums, blood in the urine (hematuria), or excessive menstrual bleeding. The abnormal bleeding and bruising occur in part because of the low number of platelets in the blood (thrombocytopenia) and also because the cancerous cells release substances that cause excessive bleeding.</p><p>The low number of red blood cells (anemia) can cause people with acute promyelocytic leukemia to have pale skin (pallor) or excessive tiredness (fatigue). In addition, affected individuals may heal slowly from injuries or have frequent infections due to the loss of normal white blood cells that fight infection. Furthermore, the leukemic cells can spread to the bones and joints, which may cause pain in those areas. Other general signs and symptoms may occur as well, such as fever, loss of appetite, and weight loss.</p><p>Acute promyelocytic leukemia is most often diagnosed around age 40, although it can be diagnosed at any age.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/acute-promyelocytic-leukemia\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>The mutation that causes acute promyelocytic leukemia involves two genes, the PML gene on chromosome 15 and the RARA gene on chromosome 17. A rearrangement of genetic material (translocation) between chromosomes 15 and 17, written as t(15;17), fuses part of the PML gene with part of the RARA gene. The protein produced from this fused gene is known as PML-RARα. This mutation is acquired during a person&#x27;s lifetime and is present only in certain cells. This type of genetic change, called a somatic mutation, is not inherited.</p><p>The PML-RARα protein functions differently than the protein products of the normal PML and RARA genes. The protein produced from the RARA gene, RARα, is involved in the regulation of gene transcription, which is the first step in protein production. Specifically, this protein helps control the transcription of certain genes important in the maturation (differentiation) of white blood cells beyond the promyelocyte stage. The protein produced from the PML gene acts as a tumor suppressor, which means it prevents cells from growing and dividing too rapidly or in an uncontrolled way. The PML-RARα protein interferes with the normal function of both the PML and the RARα proteins. As a result, blood cells are stuck at the promyelocyte stage, and they proliferate abnormally. Excess promyelocytes accumulate in the bone marrow and normal white blood cells cannot form, leading to acute promyelocytic leukemia.</p><p>The PML-RARA gene fusion accounts for up to 98 percent of cases of acute promyelocytic leukemia. Translocations involving the RARA gene and other genes have been identified in a few cases of acute promyelocytic leukemia.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/acute-promyelocytic-leukemia/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"acute-promyelocytic-leukemia","sourceDocuments":[{"name":"MedlinePlus: Acute promyelocytic leukemia","reviewed":"2011-04","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/acute-promyelocytic-leukemia"},{"name":"GARD: Acute promyelocytic leukemia","reviewed":null,"source_release":"2026-10-25T03:38:18Z","url":"https://rarediseases.info.nih.gov/diseases/538"},{"name":"MONDO: acute promyelocytic leukemia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012883"}],"sourceNote":"","synonyms":["acute myeloblastic leukaemia 3","acute myeloblastic leukemia 3","acute myeloid leukaemia with t(15;17)(q22;q12);(PML/RARalpha) and variants","acute myeloid leukemia with t(15;17)(q22;q12);(PML/RARalpha) and variants","acute promyelocytic leukaemia with PML-rara","acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-rara","acute promyelocytic leukaemia with t(15;17)(q22;q12); PML/rara","acute promyelocytic leukemia","acute promyelocytic leukemia with PML-rara","acute promyelocytic leukemia with t(15;17)(q22;q12); PML-rara","acute promyelocytic leukemia with t(15;17)(q22;q12); PML/rara","AML M3","AML with t(15;17)(q22;q12)","AML with t(15;17)(q22;q12);(PML/RARalpha) and variants","APL","APML","APML - acute promyelocytic leukaemia","APML - acute promyelocytic leukemia","FAB M3","leukemia, acute promyelocytic, somatic","promyelocytic leukaemia","promyelocytic leukemia"],"takeawayHtml":"","title":"acute promyelocytic leukemia"},"schemaVersion":1}
